Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • TOBACCO—U.S.: Supreme Court sides with FDA, e-cigarette manufacturers lose flavor expansion effort
    • AGENCY NEWS—Large scale HHS firings begin, members of Congress demand answers
    • COSMETICS—N.D. Cal.: Shampoo products’ back-label explanations of ‘natural’ claims save P&G from liability
    • DRUGS AND BIOLOGICS—D. Mass.: Court pares claims in Respimat Orange Book putative class action
    • ENFORCEMENT ACTIONS—NOTICES: DEA denies pharmacy’s registration application
    • ENFORCEMENT ACTIONS—NOTICES: DEA denies physician’s registration application
    • EXPERT INSIGHTS—23andMe's Bankruptcy Doesn't Mean Genetic Data Will Be Improperly Disclosed
    • FALSE CLAIMS ACT—5th Cir.: $29 million qui tam judgment remanded for new trial
    • GENERAL HEALTH CARE NEWS—D. Md.: Court denies transgender youths’ emergency motion to enforce preliminary injunction
    • SUPREME COURT NEWS—Court grapples with whether Medicaid beneficiary can sue over state’s decision to defund Planned Parenthood
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, ENFORCEMENT ACTIONS—NOTICES: DEA denies pharmacy’s registration application, (Apr 2, 2025)

    By WK Editorial Staff

    The applicant was deemed to have admitted, and the DEA found that the applicant repeatedly dispensed prescriptions in violation of the minimum practice standards that govern pharmacy practice in Texas.

    On December 15, 2023, the Drug Enforcement Admini ...

    By WK Editorial Staff

    The applicant was deemed to have admitted, and the DEA found that the applicant repeatedly dispensed prescriptions in violation of the minimum practice standards that govern pharmacy practice in Texas.

    On December 15, 2023, the Drug Enforcement Administration (DEA) issued an Order to Show Cause (OSC) to Baijes Bissonnet Pharmacy of Stafford, Texas. The OSC proposed the denial of the applicant’s application for DEA registration, Control No. W22147152A, alleging that the applicant’s registration was inconsistent with the public interest. The pharmacy failed to file a hearing request and had not provided good cause for its failure and, therefore, the factual allegations in the OSC were deemed admitted (Notice, 90 Fed. Reg. 14386 (Apr. 1, 2025)).

    Dates. April 1, 2025.

    FederalRegisterIssuances: Notices ControlledNews EnforcementNews PrescriptionDrugNews ProviderNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use